Author = Ali Bahrami-Samani
Production of no-carrier-added Ho-166 for targeted therapy purposes

Volume 25, Supplement 1, February 2017, Pages 15-20

Sara Vosoughi; Simindokht Shirvani-Arani; Ali Bahrami-Samani; Nafiseh Salek; Amir Reza Jalilian

Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex

Volume 25, Issue 1, January 2017, Pages 11-16

Hassan Ranjbar; Ali Bahrami-Samani; Davood Beiki; Mohammad Ghannadi-Maragheh

Production, quality control and biological evaluation of 153Sm-TTHMP as a possible bone palliation agent

Volume 19, Issue 2, December 2011, Pages 60-68

Zohreh Naseri; Amir Reza Jalilian; Ali Nemati Kharat; Ali Bahrami-Samani; Mohammad Ghannadi-Maragheh

Production of Holmium-166 DOTMP: A promising agent for bone marrow ablation in hematologic malignancies

Volume 19, Issue 1, December 2011, Pages 12-20

Reza Bagheri; Amir Reza Jalilian; Ali Bahrami-Samani; Maohammad Mazidi; Mohammad Ghannadi-Maragheh

Production and quality control of 166Ho-Chitosan for therapeutic applications

Volume 18, Issue 2, December 2010, Pages 1-8

Samaneh Zolghadri; Amir Reza Jalilian; Hassan Yousefnia; Ali Bahrami-Samani; Simindokht Shirvani-Arani; Mohammad Mazidi; Mehdi Akhlaghi; Mohammad Ghannadi-Maragheh

Development of Sm-153 chitosan for radiosynovectomy

Volume 18, Issue 1, January 2010, Pages 22-31

Ali Bahrami-Samani; Amir Reza Jalilian; Hassan Yousefnia; Mehdi Akhlaghi; Mohammad Mazidi; Mohammad Ghannadi-Maragheh

Production, quality control and biological evaluation of 153Sm-EDTMP in wild-type rodents

Volume 17, Issue 2, December 2009, Pages 12-19

Ali Bahrami-Samani; Mohammad Ghannadi-Maragheh; Amir Reza Jalilian; Simindokht Shirvani-Arani; Moein Meftahi; Sedigheh Moradkhani